Evolent Health names new board member, Shawn Guertin, with healthcare experience.

Evolent Health has announced the nomination of Shawn Guertin, former CFO of CVS Health, Aetna, and Coventry Health Care, to its Board of Directors. Guertin brings 40 years of experience in actuarial, financial, and management roles in the insurance and healthcare sectors. His nomination is part of the company's efforts to refresh its board. Guertin will stand for election at the annual meeting of stockholders on June 5, 2025.

Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, has announced the nomination of Shawn Guertin as a new independent director nominee for election to its Board of Directors. Guertin, a seasoned executive with nearly 40 years of experience in actuarial, financial, and management roles in the insurance and healthcare sectors, brings a wealth of expertise to the role. His nomination is part of Evolent's ongoing efforts to refresh its board and align its corporate governance with best-in-class practices [1].

Guertin most recently served as Executive Vice President and Chief Financial Officer for CVS Health Corporation from May 2021 to October 2023. Prior to this, he held various leadership positions at Aetna, Inc. and Coventry Health Care, Inc., including roles as Executive Vice President, CFO, and Chief Enterprise Risk Officer. His nomination follows a thorough search process conducted by the Board's Nominating and Governance Committee to fill an independent director position [1].

"If elected, Mr. Guertin will be the sixth new independent director added to the Board in the past four years," said Evolent Board Chair Cheryl Scott. "Shawn brings an impressive track record of driving growth and profitability in the health care industry, and we are excited about the opportunity to have him join the Board" [1].

Guertin will stand for election at the annual meeting of stockholders scheduled for June 5, 2025. If elected, he will take the seat currently held by Diane Holder, who is not seeking re-election. Holder's contributions to Evolent over the past 14 years have been significant, and her legacy will continue to be linked to the company's leadership in value-based specialty care [1].

Evolent Health specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable. The company serves a national base of leading payers and providers and is recognized as a top place to work in healthcare nationally [1].

References:
[1] https://www.prnewswire.com/news-releases/evolent-names-shawn-guertin-as-new-independent-nominee-for-election-to-its-board-of-directors-302433841.html